Personal information

medical oncology, breast cancer, biomarkers research

Activities

Education and qualifications (1)

Universidad de Cádiz: Cadiz, Andalucía, ES

2009-09-01 to 2015-06-15 | Medical Doctor
Education
Source: Self-asserted source
Paulo Luz

Works (27)

Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence

Clinical Drug Investigation
2023-09 | Journal article
Contributors: Inês Soares de Pinho; Paulo Luz; Lucy Alves; Raquel Lopes-Brás; Vanessa Patel; Miguel Esperança-Martins; Lisa Gonçalves; Ritas Freitas; Diana Simão; Maria Roldán Galnares et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostication in Metastatic Solid Tumours: Medical Community General Knowledge

BMJ Supportive and Palliative Care
2022 | Journal article
EID:

2-s2.0-85127683583

Part of ISSN: 20454368 2045435X
Contributors: Gameiro-Santos, R.; Fernandes, I.G.; Luz, P.
Source: Self-asserted source
Paulo Luz via Scopus - Elsevier
grade
Preferred source (of 3)‎

Tumor-infiltrating lymphocytes in early breast cancer: an exploratory analysis focused on HER2+ subtype in Portuguese patients

Current Medical Research and Opinion
2022-08-03 | Journal article
Contributors: Paulo Luz; Isabel Fernandes; Joana Magalhães; Rita Teixeira de Sousa; Pedro Faísca; João G. Costa; Ana S. Fernandes
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prevalence of fear of death among young breast cancer patients during adjuvant endocrine therapy: Results from a Portuguese Cohort,Prevalência do medo de morrer em doentes jovens com cancro de mama durante a hormonoterapia adjuvante: Resultados de uma Coorte Portuguesa

Acta Medica Portuguesa
2021 | Journal article
EID:

2-s2.0-85105458949

Part of ISSN: 16460758 0870399X
Contributors: Luz, P.; Nobre Carvalho, A.; Oliveira, A.; Menezes, M.; Dinis, R.; Gosalbez, B.
Source: Self-asserted source
Paulo Luz via Scopus - Elsevier
grade
Preferred source (of 2)‎

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer
2021 | Journal article
EID:

2-s2.0-85120908291

Part of ISSN: 23744677
Contributors: El Bairi, K.; Haynes, H.R.; Blackley, E.; Fineberg, S.; Shear, J.; Turner, S.; de Freitas, J.R.; Sur, D.; Amendola, L.C.; Gharib, M. et al.
Source: Self-asserted source
Paulo Luz via Scopus - Elsevier
grade
Preferred source (of 2)‎

SURVIVAL COMPARISON OF HER2 METASTATIC BREAST CANCER PATIENTS ACCORDING TO HORMONE RECEPTOR STATUS: PORTUGUESE MULTICENTER EXPERIENCE

The Breast
2021-10 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Immunotherapy in Metastatic Mucosal Melanoma with Disseminated Intravascular Coagulation: A Case of Success

Case Reports in Immunology
2021-10-08 | Journal article
Part of ISSN: 2090-6617
Part of ISSN: 2090-6609
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Post neoadjuvant HER2 treatment: real world data from a multicentric cohort

The Breast
2021-04 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Systemic treatment of HER2-positive breast cancer patients with brain metastases: current status and exploratory case study in a Portuguese cohort

Journal Biomedical and Biopharmaceutical Research
2021-04 | Journal article
Contributors: Paulo Luz; Elsa Campoa; Rita Gameiro; Marta Vaz; Isabel Fernandes; Joana Magalhães; Beatriz Gosalbez; Sofia Braga; João Guilherme Costa; Ana Sofia Fernandes
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort

The Breast
2021-04 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?

European Journal of Breast Health
2021-01-01 | Journal article
Contributors: Paulo Luz
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

How shall we treat locally advanced triple negative breast cancer? [version 2; peer review: 2 approved]

2020-05-04 | Journal article
Part of ISSN: 2046-1402
Contributors: Paulo Luz; David Dias; Ana Fortuna; Luis Bretes; Beatriz Gosalbez
Source: check_circle
F1000
grade
Preferred source (of 4)‎

O Desafio de Tratar Doentes Oncológicos durante a Atual Pandemia Pela COVID19

Acta Médica Portuguesa
2020-05-04 | Journal article
Part of ISSN: 1646-0758
Contributors: Paulo Luz; Luis Bretes
Source: Self-asserted source
Paulo Luz via Crossref Metadata Search
grade
Preferred source (of 3)‎

Osler Centenary Papers: Reflection on the use of antibiotics to treat ‘the old man’s friend’

Postgraduate Medical Journal
2019-12-01 | Journal article
Contributors: Paulo Luz
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Osler Centenary Papers: When the diagnosis is futile…

Postgraduate Medical Journal
2019-12-01 | Journal article
Contributors: Paulo Luz
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

EP276 Toxicity evaluation of locally advanced cervical cancer

ePoster
2019-11 | Journal article
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

EP277 Special considerations in quality of life of locally advanced cervical cancer patients

ePoster
2019-11 | Journal article
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

PRELIMINARY ANALYSIS OF TREATMENT DELAY WITH PALBOCICLIB ON PROGRESSION FREE SURVIVAL (PFS)

The Breast
2019-11 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Living longer and living better: breast cancer endocrine therapy

BMJ Supportive & Palliative Care
2019-09 | Journal article
Part of ISSN: 2045-435X
Part of ISSN: 2045-4368
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 3)‎

How shall we treat locally advanced triple negative breast cancer?

F1000Research
2019-09-16 | Journal article
Contributors: Paulo Luz; David Dias; Ana Fortuna; Luis Bretes; Beatriz Gosalbez
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

P-320Trifluridine/Tipiracil (TAS-102) in refractory metastatic colorectal cancer: Real-world data of 13 oncological centers in Portugal

Annals of Oncology
2019-07-01 | Journal article
Part of ISSN: 0923-7534
Part of ISSN: 1569-8041
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

O Desafio de Tratar Idosos com Cancro

Acta Médica Portuguesa
2019-03-29 | Journal article
Part of ISSN: 1646-0758
Part of ISSN: 0870-399X
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 3)‎

BPI19-010: Febrile Neutropenia Induced by Chemotherapy: Impact of Risk Re-Stratification

Journal of the National Comprehensive Cancer Network
2019-03-08 | Journal article
Part of ISSN: 1540-1405
Part of ISSN: 1540-1413
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Adjuvant chemotherapy in young breast cancer patients with endrocrine receptor (ER) disease

The Breast
2018-10 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Breast cancer in young women: understanding our reality

The Breast
2018-10 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Advanced Breast Cancer in Young Women: Outcome of a Portuguese Hospital

The Breast
2017-11 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎

Impact of Molecular Subtypes in Patients with Metastatic Breast Cancer at Diagnosis

The Breast
2017-11 | Journal article
Part of ISSN: 0960-9776
Source: Self-asserted source
Paulo Luz
grade
Preferred source (of 2)‎